Shanghai Haoyuan Chemexpress Co., Ltd.
SHH: 688131.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Baofu Zheng
- Employees
- 3,576
- Headquarters
- Shanghai, China
- IPO year
- 2021
- Market cap
- CN¥15.3B
- Website
- https://www.chemexpress.cn
Loading 688131…
Loading profile data…Frequently asked questions about 688131
What does Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) do?
Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
Where does 688131.SS trade?
Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) trades on the Shanghai Stock Exchange.
What sector is 688131.SS in?
Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shanghai Haoyuan Chemexpress Co., Ltd.?
Baofu Zheng is the chief executive officer of Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS).
Where is Shanghai Haoyuan Chemexpress Co., Ltd. headquartered?
Shanghai Haoyuan Chemexpress Co., Ltd. is headquartered in China.
Does 688131.SS pay a dividend?
Yes — Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) paid a trailing twelve-month dividend of CNY 0.23 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688131.SS go public?
Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) completed its initial public offering in 2021.